# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious diseas...
Aditxt and Evofem amended and restated their merger agreement.